Apotex Makes Strategic Acquisition of US Rights to PROVIGIL and NUVIGIL Apotex Inc. has successfully acquired the US rights to PROVIGIL and NUVIGIL, enhancing its portfolio in specialty healthcare and commitment to improving patient care.

Apotex Makes Strategic Acquisition of US Rights to PROVIGIL and NUVIGIL #Canada #Toronto #Provigil #Nuvigil #Apotex

Neuraxpharm Expands its Portfolio with Acquisition of Narcolepsy Treatments Provigil® and Nuvigil® Neuraxpharm has announced the acquisition of Provigil® and Nuvigil®, enhancing their CNS portfolio and expanding into new markets like Australia.

Neuraxpharm Expands its Portfolio with Acquisition of Narcolepsy Treatments Provigil® and Nuvigil® #Neuraxpharm #Provigil #Nuvigil #Spain,_Germany #Barcelona,_Düsseldorf